Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Sales

IceCure Medical (ICCM) Invested Capital (2020 - 2025)

IceCure Medical has reported Invested Capital over the past 6 years, most recently at $9.1 million for Q4 2025.

  • For Q4 2025, Invested Capital rose 31.15% year-over-year to $9.1 million; the TTM value through Dec 2025 reached $9.1 million, up 31.15%, while the annual FY2025 figure was $9.1 million, 31.15% up from the prior year.
  • Invested Capital was $9.1 million for Q4 2025 at IceCure Medical, up from $6.9 million in the prior quarter.
  • Across five years, Invested Capital topped out at $27.0 million in Q4 2021 and bottomed at $6.9 million in Q4 2024.
  • The 5-year median for Invested Capital is $12.2 million (2023), against an average of $16.1 million.
  • Year-over-year, Invested Capital surged 377.3% in 2021 and then crashed 52.16% in 2023.
  • Over 5 years, Invested Capital stood at $27.0 million in 2021, then fell by 5.7% to $25.4 million in 2022, then tumbled by 52.16% to $12.2 million in 2023, then tumbled by 43.26% to $6.9 million in 2024, then surged by 31.15% to $9.1 million in 2025.
  • The last three reported values for Invested Capital were $9.1 million (Q4 2025), $6.9 million (Q4 2024), and $12.2 million (Q4 2023) per Business Quant data.